Wolfgang Miesbach: Practice-Changing Insights on the Efficacy and Safety of Platelet Transfusions at the EHA-SWG
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Platelet transfusions in inherited platelet disorders – powerful, but never ‘routine’
At the EHA‑SWG Scientific Meeting on Bleeding and Platelet Disorders, Roger Schutgens gave a practice‑changing talk on the efficacy and safety of platelet transfusions:
Platelet transfusions remain an important possibility.
But every unit carries a price:
- alloimmunization
- refractoriness
- TRALI/TACO– particularly critical for younger patients who may need repeated support.
What is striking:
Different societies suggest different platelet thresholds for the same procedures.
Many ‘strong’ recommendations are built on low or very low evidence.
In inherited platelet disorders, where function outweighs count, a single cutoff number is simply not enough.
‘Just give platelets’ is not a strategy.
We need individualized, phenotype‑driven decisions that balance immediate bleeding risk against the long‑term consequences of transfusion.”
Stay updated with Hemostasis Today.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention